NCT06284512

Brief Summary

The progress of uveal melanoma is typically monitored with sonography by experienced onco-ophthalmologists. However, there is evidence that twodimensional measurements in color fundus photography match precisely with sonography measurements. This study aims to compare sonography and color fundus photography measurements in order to evaluate the feasibility of monitoring of uveal melanoma with color fundus photography.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 12, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

October 15, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

1.2 years

First QC Date

October 12, 2023

Last Update Submit

February 21, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Largest Basal Diameter

    Largest Basal Diameter will be measured on echography and color fundus photography

    1 day

Study Arms (1)

Uveal Melanoma

Patients with uveal melanoma will undergo a routine diagnostic imaging with color fundus photography and sonography.

Diagnostic Test: Sonography, color fundus photography

Interventions

Patients will undergo routine diagnostic imaging (Sonography, color fundus photography)

Uveal Melanoma

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with uveal melanoma will be included in this study.

You may qualify if:

  • Diagnosis of uveal melanoma

You may not qualify if:

  • Inadequate or missing information on the clinical course in patient charts
  • Imaging not feasible due to any reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna, Department of Ophthalmology and Optometry

Vienna, 1090, Austria

RECRUITING

MeSH Terms

Conditions

Uveal Melanoma

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

MelanomaNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve TissueNevi and MelanomasUveal NeoplasmsEye NeoplasmsNeoplasms by SiteEye DiseasesUveal Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Reinhard Told, MD, PhD, Priv.-Doz.

    Deparment of Ophthalmology and Optometry

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Reinhard Told, MD, PhD, Priv.-Doz.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

October 12, 2023

First Posted

February 29, 2024

Study Start

October 15, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 29, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations